MEROPENEM Fresenius i.v. subst sèche 500 mg 10 pce

7680624190016 CH-62419 J01DH02 08.01.25

Reimbursement limitations:

MERONEM

Mucoviscidose

MEROPENEM Fresenius i.v. subst sèche 500 mg 10 pce
MEROPENEM Fresenius i.v. subst sèche 500 mg 10 pce
MEROPENEM Fresenius i.v. subst sèche 500 mg 10 pce
1 / 3
google

Details

Product number
6241901
CPT
-
Packaging group
10 x 500
Unit
mg
Composition
Praeparatio sicca: meropenemum 500 mg ut meropenemum trihydricum, natrii carbonas corresp. natrium 45.1 mg, pro vitro.

Articles (1)

Meropenem Fresenius i.v. 500 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung
Pulver
10 x 500
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/11/2024
Professional SmPC
Français
25/11/2024
Professional SmPC
Italien
25/11/2024

Detailed composition

Substance Quantity Type Category
PRS
500.0 MG Substance Wirkstoff (Principe actif)
PRS
- Substance WIZUS
PRS
- Substance HNIDK
PRS
45.1 MG Substance HBESI

Reimbursement information

Public price
CHF 137.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2014

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
62419
Drug name
Meropenem Fresenius i.v., Pulver zur Herstellung einer Injektions-/Infusionslösung
Galenic form
PULPA
ATC Code
J01DH02
Authorization status
Z
Dispensation category
A
First authorization
13/12/2011
Authorization expiration date
31/12/9999
IT number
08.01.25
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
MEROPENEM Fresenius i.v. subst sèche 500 mg 10 pce
Description (DE)
MEROPENEM Fresenius i.v. Trockensub 500 mg 10 Stk
Market launch
13/12/2011
Narcotic (BTM)
No

Original drug

Meronem, Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 158.20
View original

Other packaging sizes

MEROPENEM Fresenius i.v. subst sèche 1 g 10 pce
10 x 1 G
View